Drug interactions on a GLP-1
A slower stomach changes how every oral medicine is absorbed. For most that is irrelevant — for a handful it is not, and those are worth knowing by name.
The short version
- The main mechanism is delayed gastric emptying, which changes the rate at which oral medicines are absorbed.
- For most medicines this makes no practical difference.
- It matters where the margin between an effective and a harmful dose is narrow.
- Insulin and sulfonylureas are the clearest case: doses are often reduced when a GLP-1 is started.
- Give your pharmacist a complete list. This is the step people skip and the one that catches problems.
Interaction warnings tend to be either alarming or ignored, and neither is useful. The situation with this class is unusually easy to reason about, because almost all of it comes from a single mechanism.
One mechanism, many consequences
These medicines slow the rate at which your stomach empties into the small intestine, where most absorption happens. An oral medicine taken alongside them therefore arrives at its absorption site more slowly than the manufacturer's data assumed.
For the majority of medicines, arriving slightly later changes nothing that matters — the total absorbed is the same, and the effect is judged over days rather than hours. The exceptions fall into two groups: medicines where the peak concentration matters, and medicines where a small change in level has large consequences.
One further point applies during escalation specifically. The delay is largest when a dose is new and levels are climbing, so interactions that are irrelevant at a stable maintenance dose can appear transiently in the weeks after an increase.
The ones that genuinely matter
Insulin and sulfonylureas
This is the clearest and most important interaction, and it is not about absorption. GLP-1 medicines lower glucose; insulin and sulfonylureas lower glucose. Together the risk of hypoglycaemia rises materially.
Prescribers commonly reduce the insulin or sulfonylurea dose when starting a GLP-1, and adjust further during escalation. If you take either and were not given a plan for this, ask — it is a standard part of starting and should not be left to chance. What a low feels like and what to do is here.
Warfarin and other anticoagulants
Narrow margin, and control is measured rather than assumed. Changed absorption can shift it in either direction. More frequent monitoring during the first months is a reasonable precaution and is often arranged automatically — but check that it has been.
Thyroid hormone
Levothyroxine is absorption-sensitive and has a narrow therapeutic margin. It is also usually taken on an empty stomach first thing, which is exactly the window an oral GLP-1 product occupies. If you take both, the timing needs to be worked out deliberately rather than improvised.
Oral contraceptives
Two issues. Absorption may be affected during escalation, and — more importantly — vomiting within a few hours of taking a pill can mean it was not absorbed at all. Given that pregnancy is an exclusion on the weight-management indication, this is not a minor point. We cover it properly here.
Medicines with a narrow therapeutic index
Digoxin, lithium, some anti-epileptics and some immunosuppressants share the property that a modest change in blood level produces a clinically important change in effect. None is prohibited; all warrant a specific conversation and, in some cases, level monitoring after starting.
What is not an interaction
Worth saying plainly, because uncertainty here causes people to stop medicines they should keep taking.
- Most antibiotics, painkillers and antihypertensives are unaffected in any way that matters.
- Common supplements are generally fine, though very large doses of anything are worth mentioning.
- Food is not an interaction for the injectable products — they are taken with or without it. The oral tablet is the exception, and there the rules are strict.
Combinations to avoid entirely
Two GLP-1 products are not taken together — the mechanisms overlap and the side effects compound without added benefit. The same applies to combining a GLP-1 receptor agonist with a DPP-4 inhibitor such as sitagliptin: DPP-4 inhibitors work by preventing the breakdown of your own GLP-1, so the pathway is already being addressed.
This sounds obvious and still happens, usually when a new prescriber does not have the full list.
Surgery, procedures and anaesthesia
This is the interaction people are least likely to think of and the one with the sharpest consequences. A stomach that empties slowly may still contain food after a standard fasting period, which matters for anaesthesia and for procedures such as endoscopy.
Tell any surgeon, anaesthetist or endoscopist that you take a GLP-1, well before the day. The detail is here, and it is worth reading before you book anything.
The practical step
Almost everything on this page is handled by one action: giving your pharmacist a complete list of what you take — prescription medicines, over-the-counter medicines, supplements and anything herbal — and asking them to check it against a new GLP-1 prescription.
Pharmacists are better at this than anyone else in the system and are routinely under-used for it. It takes a few minutes, it is free, and it catches the interactions that a rushed appointment does not.
Keep the list current. The risk is not usually the medicine you were taking when you started. It is the one prescribed six months later by someone who does not know about this one.
The prescription written six months later
The interaction that causes trouble is rarely the one considered at the start. It is the antibiotic prescribed by an out-of-hours service, or the new medicine started by a different specialist who does not have your full list.
Two habits cover most of it: keep a current list on your phone, and mention the GLP-1 explicitly whenever anything new is prescribed. Saying "I take a weekly GLP-1 injection" takes three seconds and prompts the check that a rushed appointment would otherwise skip.
Sources
- US Prescribing Information for the products in this class — drug interactions sections.
- Professional society guidance on the perioperative management of patients taking GLP-1 receptor agonists.
Related
- Who should not take a GLP-1 — The absolute exclusions, the conditions that require caution, and the medicines that need rethinking before you start.
- Pancreatitis: what to watch for — Rare, serious, and easy to dismiss when nausea and abdominal discomfort have become normal. How to tell the difference.
- Surgery, endoscopy and anaesthesia — A stomach that empties slowly may still hold food after a standard fast. This is the interaction people forget, and the one with the sharpest consequences.
- Pregnancy, contraception and fertility — Weight-management GLP-1s are not for use in pregnancy — and a slower stomach can affect the pill. Two facts that together catch people out.
Which medicine you are on
Everything above applies across the class, because it comes from a shared mechanism. The numbers that differ — dose ladders, missed-dose windows, in-use storage periods, half-lives — differ by product, sometimes substantially. Each medicine has its own reference here:
Ozempic · Wegovy · Mounjaro · Zepbound · Rybelsus · Saxenda · Victoza · Trulicity · all medicines
How this page is sourced. Figures come from manufacturers' approved labelling and from published clinical and pharmacokinetic literature. Regional labels differ, sometimes materially — where a number matters, the leaflet in your own box outranks anything written here. This site is not written or medically reviewed by clinicians, and we say so rather than implying otherwise; our editorial standards set out what that means and how corrections work.